Assessment |
Biopsychology |
Comparative |
Cognitive |
Developmental |
Language |
Individual differences |
Personality |
Philosophy |
Social |
Methods |
Statistics |
Clinical |
Educational |
Industrial |
Professional items |
World psychology |
Biological: Behavioural genetics · Evolutionary psychology · Neuroanatomy · Neurochemistry · Neuroendocrinology · Neuroscience · Psychoneuroimmunology · Physiological Psychology · Psychopharmacology (Index, Outline)
|
Bemegride chemical structure | |
| 4-Ethyl-4-methyl-2,6-piperidinedione IUPAC name | |
| CAS number 64-65-3 |
ATC code |
| PubChem 2310 |
DrugBank [1] |
| Chemical formula | {{{chemical_formula}}} |
| Molecular weight | 155.2 g/mol |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Pregnancy category | |
| Legal status | |
| Routes of administration | |
Bemegride is a CNS stimulant and antidote for barbiturate poisoning. As a stimulant is approximately as potent as phendimetrazine or pemoline.
Bemegride is also known as Megimide.
Animal use[edit | edit source]
Bemegride is also used to induce convulsions in experimental animals.[1]
See also[edit | edit source]
References[edit | edit source]
| This page uses Creative Commons Licensed content from Wikipedia (view authors). |
